People

James D. Skinner - President and CEO
Jim is a seasoned and successful CEO and entrepreneur having managed three publicly traded life sciences companies, several private companies and been the founder of a number of start-up firms. As CEO, Jim has raised more than $100 million. He currently is a member of the Board of Associates of the Whitehead Institute, the world’s leading biotechnology research organization, and has been a founder and/or board member of several biotechnology organizations including the Biotechnology Industry Organization, Washington, DC.

Thomas Russell. Ph.D. - Vice President Research and Development & CSO
Tom is the Founder of and an investor in RBI. He has over 25 years experience in the field of cell selection using microparticle technology. Dr Russell was President and Founder of TRC Biotech, LLC which is now a wholly owned subsidiary of RBI. Prior to founding TRC Biotech, he was Vice President of Reagent Development at Immunicon Corporation and spent the previous 14 years at Coulter Corporation, including serving as Director of Research and Technology. While at Coulter he was a co-inventor of a cell selection procedure that was licensed to Eligix, Inc. for therapeutic applications and was a co-inventor of Coulter’s Q-Prep technology that revolutionized sample processing for Flow Cytometry. The product became the industry standard. Dr. Russell is an inventor on 17 U.S. patents and an author on over 40 publications.

Nancye Files - Vice President of Marketing
Nancye has had extensive industry experience in the research and diagnostic markets with leading edge technologies for cell identification and analysis in immunology, oncology, and genetics. She has held various marketing positions in both start up companies (Oncor, IMI and Immunicon) and major diagnostic companies (Coulter and Becton Dickinson Immunocytometry Systems), with both national and international responsibilities.

Advisors & Consultants

Michael Musick, Ph. D. is responsible for the manufacture and characterization of the company’s ferromagnetic particles and is a co-inventor of the company’s ferromagnetic selection technology. Currently employed in the field of micro and nano particles, Dr. Musick has synthesized numerous particles and surface treatments. His efforts in analytical research are diverse ranging from the fields of micro and nano structural analysis, surface characterization, material property measurement, and chemical coatings to clinical diagnostics and genetic screening. He received his B.S. in chemistry from the University of Pittsburgh in 1994 and a Ph.D. from the Pennsylvania State University in 1999 studying nanostructure assemblies and new immunological detection strategies. He is the co-author of 14 scientific publications and a co-inventor on seven patents.

Judith H. Smith, Ph.D. is an independent consultant with expertise in product marketing and web design. Dr. Smith was previously employed by Beckman Coulter, Inc. where she held several positions including scientific liaison for products designed to detect enzyme activity using flow cytometric evaluation, manager of the technical support group for coagulation products and scientist in R&D for flow cytometry products. She also has eight years experience in clinical labs performing diagnostic testing in the field of immunology, specializing in characterization of leukemias/lymphomas, DNA analysis of solid tumors, and detection of microbiological pathogens using PCR. Dr. Smith received her Ph.D. in Immunology and Medical Microbiology from the University of South Florida College of Medicine.

Russell Biotech, Inc. Phone: 215-589-6412 Fax: 215-489-4920 email: trussell@russellbiotech.com